Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Abstract

Laquinimod; relapsing-remitting multiple sclerosis; MRI monitoring

Keywords

• Laquinimod
• relapsing-remitting multiple sclerosis
• MRI monitoring